ABI-008 Trial in Patients With Hormone-refractory Prostate Cancer

Clinical trial NCT00477529 · COMPLETED

Trial details

NCT number: NCT00477529
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hormone Refractory Prostate Cancer

Start date: 2007-04-01
Primary completion: 2011-06-02
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.